Product Details:
Strength / Dose | 40 mg / 0.8 ml |
Manufacturer | Zydus |
Packaging Type | Vial |
Composition | Adalimumab (40mg) |
Shelf Life | 36 Months |
Usage | Rheumatoid arthritis, Psoriatic Arthritis |
Form | Injection |
Exemptia 40mg Injection contains the active ingredient Adalimumab. It is an antirheumatic agent that belongs to the class of medications called TNF (tumor necrosis factor) inhibitors. It is used alone or with other medications to relieve the symptoms of certain autoimmune disorders. It is used to treat rheumatoid arthritis (a condition in which the body attacks its joints, causing pain, swelling, and loss of function), polyarticular juvenile idiopathic arthritis (a condition that affects children in which the body attacks its own joints, causing pain, swelling, loss of function, and delays in growth and development).